Literature DB >> 1638575

Mitochondrial dysfunction observed in situ in cardiomyocytes of rats in experimental diabetes.

Y Tanaka1, N Konno, K J Kako.   

Abstract

OBJECTIVE: The aim was to investigate effects of experimental diabetes and insulin treatment on heart myocytes, particularly on the mitochondrial function studied in situ in isolated cardiomyocytes.
METHODS: 20 male Sprague-Dawley rats (140-160 g) were made diabetic by intraperitoneal streptozotocin, 70 mg.kg-1. Ten then received daily subcutaneous injections of ultra lente insulin (starting dose of 3 units.d-1) for 7-15 d from the 20th day after streptozotocin. There was a control group of 11 rats. The rats were killed 21-35 d after the induction of diabetes, and heart myocytes were isolated by collagenase digestion. The 45[Ca]2+ uptake of mitochondria in situ in permeabilised myocytes, the transmembrane potential gradient of mitochondria, and the respiration of myocytes, as well as the cell yield and cell [45Ca]2+ uptake, were examined.
RESULTS: Mitochondrial uptake of [45Ca]2+ was significantly decreased in the diabetic group compared to control at cytosolic calcium concentrations between 760 nM and 44.6 microM. The mitochondrial potential of diabetic myocytes, estimated from the distribution of [3H]triphenylmethylphosphonium+, was slightly but significantly decreased from the control value. Cell respiration, measured polarographically in the presence of pyruvate and malate or succinate as oxidisable substrates, and with or without 2,4-dinitrophenol, was decreased by diabetes. The rapidly exchangeable [45Ca]2+ content in the myocyte with intact sarcolemmal membrane ("cell Ca2+ uptake") and the yield of cells from heart tissue were also diminished in diabetic rats. These changes were returned to normal by insulin treatment of 7 d or longer.
CONCLUSIONS: Insulin deficiency at early stages causes defects of mitochondrial function detectable in situ in cardiomyocytes. This suggests the possibility that such alterations are causative factors in the development of diabetic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1638575     DOI: 10.1093/cvr/26.4.409

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  26 in total

1.  Restoring mitochondrial calcium uniporter expression in diabetic mouse heart improves mitochondrial calcium handling and cardiac function.

Authors:  Jorge Suarez; Federico Cividini; Brian T Scott; Kim Lehmann; Julieta Diaz-Juarez; Tanja Diemer; Anzhi Dai; Jorge A Suarez; Mohit Jain; Wolfgang H Dillmann
Journal:  J Biol Chem       Date:  2018-04-06       Impact factor: 5.157

Review 2.  Mitochondria as a target of cardioprotection in models of preconditioning.

Authors:  Magdaléna Jašová; Ivana Kancirová; Iveta Waczulíková; Miroslav Ferko
Journal:  J Bioenerg Biomembr       Date:  2017-07-20       Impact factor: 2.945

Review 3.  Diabetes and the risk of heart failure.

Authors:  Ravi Dhingra; Ramachandran S Vasan
Journal:  Heart Fail Clin       Date:  2011-10-13       Impact factor: 3.179

4.  Characterization of mammalian translocase of inner mitochondrial membrane (Tim44) isolated from diabetic newborn mouse kidney.

Authors:  J Wada; Y S Kanwar
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

Review 5.  In situ study of myofibrils, mitochondria and bound creatine kinases in experimental cardiomyopathies.

Authors:  V Veksler; R Ventura-Clapier
Journal:  Mol Cell Biochem       Date:  1994 Apr-May       Impact factor: 3.396

6.  Oxidant-NO dependent gene regulation in dogs with type I diabetes: impact on cardiac function and metabolism.

Authors:  Caroline Ojaimi; Shintaro Kinugawa; Fabio A Recchia; Thomas H Hintze
Journal:  Cardiovasc Diabetol       Date:  2010-08-24       Impact factor: 9.951

7.  Modulation of dynamin-related protein 1 (DRP1) function by increased O-linked-β-N-acetylglucosamine modification (O-GlcNAc) in cardiac myocytes.

Authors:  Thomas Gawlowski; Jorge Suarez; Brian Scott; Moises Torres-Gonzalez; Hong Wang; Raphaela Schwappacher; Xuemei Han; John R Yates; Masahiko Hoshijima; Wolfgang Dillmann
Journal:  J Biol Chem       Date:  2012-06-28       Impact factor: 5.157

Review 8.  Diabetic cardiomyopathy.

Authors:  F S Fein; E H Sonnenblick
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

Review 9.  [Heart failure in diabetes].

Authors:  Michael Resl; Martin Hülsmann; Richard Pacher; Martin Clodi
Journal:  Wien Med Wochenschr       Date:  2009

10.  Expression of the mitochondrial calcium uniporter in cardiac myocytes improves impaired mitochondrial calcium handling and metabolism in simulated hyperglycemia.

Authors:  Julieta Diaz-Juarez; Jorge Suarez; Federico Cividini; Brian T Scott; Tanja Diemer; Anzhi Dai; Wolfgang H Dillmann
Journal:  Am J Physiol Cell Physiol       Date:  2016-09-28       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.